載入...
Development of personalized treatments in lung cancer: focusing on the EGFR mutations and beyond
Lung cancers with epidermal growth factor receptor (EGFR) gene mutation account for ∼40% of adenocarcinoma in East Asians and ∼15% of that in Caucasians, which makes them one of the most common molecularly defined lung cancer subsets. The role of EGFR mutation as a strong predictive biomarker of res...
Na minha lista:
發表在: | Lung Cancer (Auckl) |
---|---|
Main Authors: | , |
格式: | Artigo |
語言: | Inglês |
出版: |
Dove Medical Press
2013
|
主題: | |
在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5217442/ https://ncbi.nlm.nih.gov/pubmed/28210134 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/LCTT.S49603 |
標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|